Skip to main content
. 2014 Nov 13;8(1):120–126. doi: 10.1093/ckj/sfu117

Table 2.

Causes of death in all patientsa

AL-λ (n = 198) AL-κ (n = 33) Total
Cardiovascular disease 29 6 35
Infection 17 3 20
Disease progression 13 3 16
Treatment complication 5 1 6
Dialysis complication 4 1 5
Liver failure 2 1 3
Lung cancer 1 0 1
Seizure 0 1 1
Unknown causes of death 12 2 14
Deaths 83 (41.9%) 18 (54.5%) 101 (43.7%)

aThere is no difference between AL-λ group and AL-κ group.